← Back to Screener
Bio Green Med Solution, Inc. Common Stock (BGMS)
Price$1.50
Value ScoreC
Growth ScoreA
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-8.59%
Price vs S&P 500 (4W)70.46%
VGM Score69.13
Market Capitalization$8.28M
All Metrics
Book Value / Share (Quarterly)$1.22
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.33
Price vs S&P 500 (YTD)-6.81%
Gross Margin (TTM)18.43%
Net Profit Margin (TTM)-117.77%
EPS (TTM)$-1.65
10-Day Avg Trading Volume12.85M
EPS Excl Extra (TTM)$-1.65
EPS (Annual)$-1.37
Dividend / Share (Annual)$0.02
ROI (Annual)-43.82%
Gross Margin (Annual)18.47%
Net Profit Margin (5Y Avg)-7621.91%
Cash / Share (Quarterly)$0.60
Revenue Growth QoQ (YoY)710.00%
ROA (Last FY)-36.63%
Revenue Growth TTM (YoY)10792.86%
EBITD / Share (TTM)$-1.09
ROE (5Y Avg)-788.35%
Operating Margin (TTM)-152.13%
Cash Flow / Share (Annual)$-0.88
P/B Ratio1.22x
P/B Ratio (Quarterly)0.82x
Net Interest Coverage (TTM)-284.57x
ROA (TTM)-44.00%
EPS Incl Extra (Annual)$-1.37
Current Ratio (Annual)4.70x
Quick Ratio (Quarterly)5.81x
3-Month Avg Trading Volume1.53M
52-Week Price Return-83.46%
P/S Ratio (Annual)11.08x
Asset Turnover (Annual)0.09x
52-Week High$23.22
Operating Margin (5Y Avg)-8498.71%
EPS Excl Extra (Annual)$-1.37
26-Week Price Return-0.66%
Quick Ratio (Annual)3.66x
13-Week Price Return56.23%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)7.06x
Enterprise Value$4.94M
Asset Turnover (TTM)0.19x
Inventory Turnover (Annual)1.67x
Pretax Margin (Annual)-400.40%
Cash / Share (Annual)$0.65
3-Month Return Std Dev111.72%
Gross Margin (5Y Avg)62.05%
ROE (Last FY)-43.82%
Net Interest Coverage (Annual)-110.66x
EPS Basic Excl Extra (Annual)$-1.37
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-1.65
ROI (TTM)-51.20%
Dividend Growth Rate (5Y)-39.23%
P/S Ratio (TTM)5.43x
Pretax Margin (5Y Avg)-8353.92%
Revenue / Share (Annual)$0.34
Price vs S&P 500 (52W)-107.83%
Year-to-Date Return1.35%
5-Day Price Return40.19%
EPS Normalized (Annual)$-1.37
ROA (5Y Avg)-137.62%
Net Profit Margin (Annual)-401.34%
Month-to-Date Return36.36%
EBITD / Share (Annual)$-1.59
Operating Margin (Annual)-465.86%
ROI (5Y Avg)-788.35%
EPS Basic Excl Extra (TTM)$-1.65
P/B Ratio (Annual)1.06x
Dividend / Share (TTM)$0.03
Inventory Turnover (TTM)3.39x
Pretax Margin (TTM)-115.48%
Book Value / Share (Annual)$1.27
Price vs S&P 500 (13W)47.98%
Dividend Yield (TTM)0.98%
Beta-0.46x
Revenue / Share (TTM)$0.28
ROE (TTM)-51.20%
52-Week Low$0.73
vGradeC
gGradeA
mGradeC
vgmGradeB
Show chart for
Analyst Recommendations
Nov 2024
Dec 2024
Jan 2025
Feb 2025
4.13
2.17
2.17
2.17
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
BGMSBio Green Med Solution, Inc. Common Stock | C | A | C | $1.50 |
| LLYEli Lilly & Co. | D | B | B | $1131.42 |
| JNJJohnson & Johnson | D | C | B | $232.77 |
| ABBVABBVIE INC. | D | C | C | $227.23 |
| MRKMerck & Co., Inc. | C | C | B | $120.79 |
| NVSNovartis AG | C | C | C | $149.16 |
| AZNAstraZeneca PLC | D | B | C | $185.95 |
| NVONovo-Nordisk A/S | B | B | B | $42.96 |
| ABTAbbott Laboratories | C | C | D | $91.07 |
| PFEPfizer Inc. | B | C | C | $26.04 |
| BMYBristol-Myers Squibb Co. | B | C | B | $57.27 |
About
Bio Green Med Solution Inc is a clinical-stage biopharmaceutical company developing targeted cancer therapies through CDK and PLK inhibitor programs, including lead candidates fadraciclib and plogosertib. The company addresses proliferative diseases by targeting cell cycle pathways and operates from the United Kingdom.